Is Aster DM Healthcare (ASTERDM) overvalued or fairly valued?

MarketChacha shows Aster DM Healthcare's valuation in context — a forward P/E of about 40.3, a price-to-book of about 8.8 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is Aster DM Healthcare's revenue?

Aster DM Healthcare reported revenue of ₹4,643 Cr for FY2026, with net profit of ₹388 Cr, per official filings.

What is the share price of Aster DM Healthcare (ASTERDM)?

Aster DM Healthcare last traded at ₹785.35 (+3.3% on the day), as of 9/4/2026 — a delayed quote shown for education, not investment advice.

Aster DM Healthcare

ASTERDM · NSE · Healthcare · India

Snapshot

TickerASTERDM

ExchangeNSE

SectorHealthcare

IndustryMedical Care Facilities

CountryIndia

CEOMr. S. Ramesh Kumar

HeadquartersHyderabad, India

Websitewww.asterqualitycare.com

Filings tracked0

About Aster DM Healthcare

Aster DM Quality Care Limited operates as an integrated healthcare provider in India. The company operates through four healthcare brands including Aster DM, CARE Hospitals, Evercare, and KIMSHEALTH. It offers comprehensive healthcare services including primary, secondary, tertiary and quaternary care across key areas including oncology, cardiac sciences, neurosciences, gastro sciences, orthopedics, nephrology, organ transplantation, mother and childcare, and critical care. In addition, the company operates retail pharmacies and optical outlets. Aster DM Quality Care Limited was formerly known as Aster DM Healthcare Limited and changed its name to Aster DM Quality Care Limited in July 2026. The company was founded in 1987 and is based in Hyderabad, India.

Who owns it

Promoters64.3%
Institutions20.2%
Public & other15.6%

75 institutional holders

Ownership breakdown from public market data. Promoter pledge is not included here — that comes from exchange shareholding filings.

Forensic scorecard

Profit has grown much faster than revenue while recent results carried sizeable one-off items — some of the profit growth may not repeat.

Net margin trend3.6% → 8.4%

Margin has expanded by about 4.8 points — the business is getting more profitable.

Growth qualityrev -27% · PAT -3%

Profit has grown much faster than revenue while recent results carried sizeable one-off items — some of the profit growth may not repeat.

One-off items1 of last 3 yrs

Recent reported profit includes sizeable one-off / non-operating items — the underlying operating trend may differ from the headline.

Computed by MarketChacha from reported figures (Yahoo Finance). Education, not a rating or recommendation.

What's expected next

Next fiscal year

Rev ₹13,120 Cr · EPS 19.47

Est. earnings growth +41.5%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: Yahoo Finance

Annual

Quarterly · last 5

Revenue (FY2026)

₹4,643 Cr

Net margin

8.4%

Revenue CAGR (3y)

-27.0%

Profit CAGR (3y)

-3.0%

Net profit (FY2026)

₹388 Cr

Ask MarketChacha about ASTERDM

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	Net margin
FY2026	₹4,643 Cr	₹388 Cr	8.4%
FY2025	₹4,138 Cr	₹5,378 Cr*	—
FY2024	₹13,978 Cr	₹129 Cr	0.9%
FY2023	₹11,933 Cr	₹425 Cr	3.6%

* Net profit includes one-off / non-operating items (e.g. a settlement or accounting gain), so it doesn’t reflect operating performance — net margin is hidden for that period.

Quarterly

Period	Revenue	Net profit	Net margin
Q1 FY27	₹1,311 Cr	₹16 Cr	1.2%
Q4 FY26	₹1,182 Cr	₹140 Cr	11.9%
Q3 FY26	₹1,186 Cr	₹52 Cr	4.4%
Q2 FY26	₹1,197 Cr	₹110 Cr	9.2%
Q1 FY26	₹1,078 Cr	₹86 Cr	7.9%

Figures as reported, in ₹ (crore). Source: Yahoo Finance.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.